Korro Bio, Inc. (KRRO) is a biotech that is working on advancing its RNA editing platform OPERA to treat certain types of disorders. The first RNA edited oligonucleotide drug of its kind from this ...
Stuart Milstein appointed Chief Platform Officer, bringing decades of experience in oligonucleotide drug development to underpin Aerska’s ...
Takara Bio USA, Inc. today announced the launch of its CSP Program and announced the certification of Admera Health on the ...
A new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both a key player in tumor biology and a promising avenue for future therapies.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of the ddSEQ™ Single-Cell 3' RNA-Seq Kit and ...
When a gene is expressed, its DNA sequence is transcribed into a molecule known as RNA. Then the cell processes and edits that RNA before it is translated into protein. Many genes can be processed and ...
Key market opportunities in the RNA extraction and purification sector include the growing demand for RNA-based therapies and diagnostics, the development of user-friendly and automated kits, and the ...
When a gene is active, there is cellular machinery that transcribes the sequence of that gene from DNA into messenger RNA. This is a fundamental cellular process that is essential to the proper ...
In recent decades, significant advances in science and technology have greatly enhanced understanding of the many biological molecules that contribute to life’s complexity. RNA is one such molecule ...
The RNA world hypothesis posits that molecules made up of ribonucleic acids (RNA) are responsible for kickstarting evolution ...
The intricate dynamics of RNA biology in plant interactions with biotic factors, including both microbes and insects, have a major impact on plant health and productivity. Understanding the molecular ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results